Article Details
Retrieved on: 2018-04-16 19:37:30
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Renaissance Technologies</b> LLC lifted its position in Dicerna Pharmaceuticals (NASDAQ:DRNA) by 19.3% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission. The firm owned 560,300 shares of the biopharmaceutical company's stock after buying an ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here